(0) items in cart / view cart / checkout  
 
 
  Aerospace and Defense
  Automotive
  Chemicals
  Consumer Packaged Goods
  Energy and Utilities
  Financial Services
  Geography
  Government and Non-Profit Organisations
  Industrial Goods and Machinery
  Ingredients
  Knowledge Center
  Leisure and Arts
  Media
  Paper and Packaging
  Pharmaceuticals and Healthcare
  Retailing
  ServiceLine
  Technology and Communications
  Textiles
  Transport and Logistics
  Wholesale
 
Home >  R&D Strategies: Incremental improvements and paradigm shifts in strategy are both necessary to boost productivity

 
R&D Strategies: Incremental improvements and paradigm shifts in strategy are both necessary to boost productivity


Introduction

Waves of technological advancements have powered significant evolution in R&D from serendipitous drug discovery, through to rational drug design. However, as the low-hanging fruit has been picked, and recent technological advances have failed to yield high numbers of new therapies, the search is on to identify R&D strategies to improve R&D productivity

Scope


Overview of the pressures facing drug developers, including an analysis of whether the industry is facing an R&D productivity crisis

In-depth analysis of R&D deal activity, together with a pipeline snapshot, to identify trends that are shaping the R&D environment

Identification of strategy optimization recommendations designed to drive up R&D productivity

Evaluation of case-studies of Big Pharma R&D strategies to determine how these companies are addressing the productivity problem


Highlights

Over the last decade, significant investment in novel technologies has failed to yield a substantial increase in innovative drugs

To drive up future productivity, drug developers are making either incremental changes to fine-tune the R&D process or they are implementing paradigm changes to radically alter the way that R&D is carried out

R&D productivity depends on accelerating and boosting the output of drug discovery and development, and there are a range of strategies to do this, including optimizing the R&D model and improving the R&D process

Reasons to Purchase


Gain a clear understanding of the factors driving drug developers to change R&D strategies

Gain insight into the trends in R&D clinical pipeline deal activity and pipeline focus

Understand how a wide of strategies can optimize R&D productivity and identify how these can best be implemented


     
  Published Price
08/09/2007
   $15200.00
   Free Shipping Worldwide

 
 
VPGDataMonitor.com © Copyright 2008. all rights reserved. Web Design by Spida Design